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Introduction
Control of cell fate, including the mechanisms that govern cell
proliferation, differentiation and death, is a central theme in
developmental neurobiology. Previous studies have indicated
the importance of neurotrophic factors in neurogenesis
(Yoshimura et al., 2001; Tao et al., 1997; Borghesani et al.,
2002) and of cellular dialogue in cell fate decisions (Renfranz
et al., 1991; Vicario-Abejón et al., 1995; Suhonen et al., 1996;
Alder et al., 1999). Besides contributing to a better
understanding of these biological processes, identification of
the instructive and permissive factors and their signaling
pathways will provide leads for prevention and cell-
replacement strategies in neurodegenerative and other diseases
of the brain.
Granule cells of the cerebellum and hippocampal dentate
gyrus share several morphological commonalities (Ramon y
Cajal, 1911); in addition, they both display dependencies
on, or expression of, a common set of growth factors and
signaling pathways (Dreyfus, 1998). However, cerebellar and
hippocampal granule cells show distinct differences in their
repertoire of glutamate receptor subtypes (Monyer et al., 1994)
and gene expression profiles (Saito et al., 2002), features that
most probably reflect their different physiological roles. These
similar, but also divergent, properties make these two types of
granule neuron interesting models for analyzing the intrinsic
factors responsible for the regulation of their proliferation and
maturation. Both dentate and cerebellar granule cells first
appear late in embryogenesis, with peak numbers appearing
during the first postnatal week (Altman, 1972; Altman and
Bayer, 1990; Schlessinger et al., 1975). Hippocampal granule
cells continue to proliferate throughout life, although the rate
of proliferation wanes with age (Altman and Bayer, 1990;
Kuhn et al., 1996; Cameron and McKay, 2001). By contrast,
the genesis of cerebellar granule cells terminates within the
first two weeks of life (Altman, 1972). Interestingly, gene
profiling studies revealed that genes involved in oncogenesis
and ribosomal protein synthesis are most strongly expressed at
the peak of cerebellar granule cell production (Saito et al.,
2002); of the five gene clusters analyzed in that study, none
showed any particular temporal pattern of expression in the
dentate gyrus.
To examine the hypothesis that tissue-specific factors
may serve as ‘start’ and ‘stop’ controls of proliferation in
different brain areas, we here measured neurogenesis by
Hippocampal granule cells self-renew throughout life,
whereas their cerebellar counterparts become post-mitotic
during early postnatal development, suggesting that locally
acting, tissue-specific factors may regulate the proliferative
potential of each cell type. Confirming this, we show that
conditioned medium from hippocampal cells (CMHippocampus)
stimulates proliferation in cerebellar cultures and, vice
versa, that mitosis in hippocampal cells is inhibited by
CMCerebellum. The anti-proliferative effects of CMCerebellum
were accompanied by increased expression of the cyclin-
dependent kinase inhibitors p21 and p27, as well as markers
of neuronal maturity/differentiation. CMCerebellum was found
to contain peptide-like factors with distinct anti-
proliferative/differentiating and neuroprotective activities
with differing chromatographic properties. Preadsorption of
CMCerebellum with antisera against candidate cytokines
showed that TGFβ2 and BDNF could account for the major
part of the anti-proliferative and pro-differentiating
activities, an interpretation strengthened by studies
involving treatment with purified TGFβ2 and BDNF.
Interference with signaling pathways downstream of TGFβ
and BDNF using dominant-negative forms of their respective
receptors (TGFβ2-RII and TRKB) or of dominant-negative
forms of SMAD3 and co-SMAD4 negated the anti-
proliferative/differentiating actions of CMCerebellum.
Treatment with CMCerebellum caused nuclear translocation of
SMAD2 and SMAD4, and also transactivated a TGFβ2-
responsive gene. BDNF actions were shown to depend on
activation of ERK1/2 and to converge on the SMAD
signaling cascade, possibly after stimulation of TGFβ2
synthesis/secretion. In conclusion, our results show that the
regulation of hippocampal cell fate in vitro is regulated
through an interplay between the actions of BDNF and
TGFβ.
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bromodeoxyuridine (BrdU) incorporation in
immunochemically characterized cells after exchanging
conditioned medium (CM) between rat postnatal day 4 (P4)
hippocampal and P7 cerebellar granule cell cultures; medium
exchanges were performed over a period covering the
appearance of the subgranular (secondary germinative) layer
of the hippocampus (Altman and Bayer, 1990) and the start of
the disappearance of the external granule layer of the
cerebellum (Altman, 1972). Our studies reveal that TGFβ2 and
BDNF of cerebellar origin have strong anti-proliferative and
neuronal differentiating properties when applied to mitotic
hippocampal granule cells.
Materials and methods
Primary cell cultures and conditioned medium
Hippocampal, cerebellar and cortical primary cell cultures were
prepared as previously described (Crochemore et al., 2005). Briefly,
hippocampal (P4) and cerebellar (P7) cells obtained from P4 Wistar
rats were dissociated using the Papain Dissociation System
(Worthington Biochemicals) and plated on poly-d-lysine-coated glass
coverslips (400 cells/mm2). Cultures were maintained (37°C, 5%
CO2/95% air, 90% relative humidity) in Neurobasal A medium/B27
Supplement and 1 mM GlutamaxI and 0.1 mg/ml kanamycin (all from
Invitrogen), half of which was renewed every 3 days. Experiments
were started 8-14 days after plating. Immunocytochemical analysis
revealed that the cultures comprised ~40% neurons (NeuN-, TuJ1- or
doublecortin-immunopositive), ~10% astroglial cells (glial fibrillary
acidic protein-positive) and ~50% progenitor (nestin-positive) cells.
Twenty-four hours before experiments, the culture medium was
completely replaced with conditioned medium (CM) from either
cerebellar (CMCerebellum) or hippocampal (CMHippocampus) cultures
containing BrdU (20 µM). Treated cultures were fixed with 4%
paraformaldehyde (PFA) 24 hours later and processed for the
immunocytochemical detection of BrdU.
Slice culture
Cerebellar and hippocampal ‘interface’ slice cultures were prepared
from P7 Wistar rats based on a protocol published by Noraberg et al.
(Noraberg et al., 1999). Briefly, hippocampal and cerebellar slices
(400 µm) were placed on Millicell semiporous membranes in six-well
plates (Millipore). Slices from each brain area were placed adjacent
to each other in a single well and bathed in 50% OPTI-
MEM/Dulbecco’s modified Eagle’s Medium (DMEM), including
10% fetal bovine serum, 15% horse serum, 1 mM Glutamax and 0.1
mg/ml kanamycin in Hank’s buffered saline solution (all from
Invitrogen). Co-cultures were maintained at 37°C (90% humidity) for
16 days, with medium changes every 3 days. Cultures were treated
with BrdU (20 µM, 24 hours) before fixation (4% PFA).
HiB5 hippocampal cell line
Neural precursor SV40 T large antigen-immortalized HiB5 cells
(Renfranz et al., 1991) (kindly provided by Dr Nina Rosenqvist, Lund,
Sweden) were maintained in DMEM containing 10% fetal calf serum
and 1% kanamycin at the permissive temperature (32°C) and a 5%
CO2 environment.
Immunocytochemistry
Slice and dispersed cell cultures were fixed in 4% paraformaldehyde,
permeabilized (0.3% Triton-X100/PBS) and incubated in 3% donkey
serum/0.3% Triton (30 minutes) before incubation (1 hour; room
temperature) with primary antibodies diluted 1:500 in 3% donkey
serum/0.3% Triton X-100 in PBS: anti-BrdU (DAKO), anti-Nestin
(Chemicon), anti-TuJ1 (Babco), anti-MAP2 (Sigma), anti-
doublecortin (Santa Cruz Biotechnology), anti-GFAP (Sigma), anti-
αMash1 and anti-αMath1 (kind gifts from Dr Jane Johnson, Dallas,
TX). After washing in PBS, cells and slices were incubated (30
minutes, room temperature) with biotinylated anti-mouse or anti-
rabbit secondary antibody (1:500; Sigma), washed and incubated (30
minutes) with FITC- or horseradish peroxidase-conjugated Avidin
(1:500; Sigma). HRP was developed with diaminobenzidine. In some
instances, nuclear staining was achieved using Hoechst 33342 (1:1000
in PBS; 15 minutes; Roche). Cells staining positive for BrdU or one
of the various neural markers were counted with respect to the total
number of cells in five randomly chosen microscopic fields (0.072
mm2; 400 magnification) across the long axis of each object; an
average of 1000 cells were sampled on each coverslip and the results
shown represent values from 6-10 coverslips per treatment.
Cell death assay
Cell death was examined in 4% PFA-fixed cells by TUNEL
histochemistry (Almeida et al., 2000) or Hoechst 33342 staining.
Apoptotic cells were identified as dark-brown nuclear staining
showing DNA fragmentation without plasma membrane damage. The
relative number of apoptotic versus total number of cells was
measured in at least five randomly chosen microscopic fields (400
magnification).
Western blotting
Cells were harvested in lysis buffer, briefly sonicated (on ice). Lysates
were cleared by centrifugation, and proteins were electrophoretically
resolved on 10 or 8% SDS polyacrylamide gels before transfer onto
nitrocellulose membranes. Membranes were blocked (5% non-fat
milk and 0.2% Tween-20 in PBS), and incubated with specific primary
antibodies (anti-MAP2a/b, Sigma, 1:5000; anti-synapsin, Chemicon,
1:400; anti-p21, Pharmingen, 1:500; anti-p27, Santa Cruz, 1:200).
Antigens were revealed by enhanced chemoluminescence (Amersham
Biosciences) after incubation with appropriate horseradish
peroxidase-IgG conjugates (Amersham).
Concentration and purification of conditioned medium
from cerebellar cultures (CMCerebellum)
A total of 1 L of CMCerebellum was collected from cultures between 8
and 14 days in vitro (d.i.v.). A 100-fold concentrate, containing
peptides with a Mr greater than 6 kDa, was prepared using Vivaspin
columns (Vivascience) before running through Q-ion exchange
columns (Vivapure 20; Vivascience) and elution with a sequential salt
gradient buffer. Bio-active fractions were further separated on Affigel
blue columns (BioRad) and analyzed for their proliferative,
differentiating and apoptotic properties (see above).
Heat lability test
Concentrated (100) CMCerebellum was boiled for 15 minutes before
addition to hippocampal cultures and measurement of bioactivity (cell
proliferation and neuronal markers).
Immunoneutralization
Antibodies against brain-derived neurotrophic factor (BDNF) and
nerve growth factor (NGF) were purchased from Santa Cruz
Biotechnology; antibodies against TGFβ2 were from R&D Systems.
All antisera were purified IgG, and species-matched purified IgG
preparations (Chemicon) were used in controls. CMCerebellum was
adsorbed with these antisera for 1 hour (room temperature) before
being added to cell cultures at dilutions ranging from 1:10 to 1:10,000,
after which the biological activity of the CMCerebellum was assessed
(see above).
BDNF studies
Results from the BDNF immunoneutralization experiments were
confirmed by adding BDNF (hBDNF, 10-100 ng/ml; Alomone
Laboratories) to hippocampal cultures at 7 d.i.v., and monitoring for
BrdU incorporation and MAP2a/b expression after 24 hours.
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Further verification of BDNF effects was obtained by transiently
transfecting primary hippocampal cultures with a BDNF expression
vector (pcDNA3-BDNF-Citron, kindly provided by Dr Oliver
Griesbeck, Martinsried, Germany) or pEGFP (as control).
Transfection was carried out using 1 µg DNA/well and Lipofectamine
2000 (Invitrogen) under serum-free conditions. Twenty-four hours
after transfection, media were exchanged between BDNF- and EGFP-
transfected cells, and BrdU (20 µM) was added to the cultures. BrdU
incorporation was assessed after a further 24 hours.
MAP kinase mediation of the pro-mitotic actions of BDNF was
examined by assaying BrdU retention and MAP2a/b expression after
treating cultures with the MEK inhibitor PD98059 (0.1 µM;
Calbiochem). The ability of BDNF (100 ng/ml) to stimulate
cytoplasm-to-nucleus translocation of key TGFβ signaling partners
was analyzed by transiently transfecting hippocampal cultures with
fluorescence-tagged Smad2 and Smad4 (see below) and microscopic
examination.
Cellular contents of TGFβ2 after BDNF or CMCerebellum treatment
were measured by semi-quantitative immunocytochemistry, using
recombinant TGFβ2 standards and ABTS [2,2’-azino-di-(3
ethylbenzthia-zoline sulfonic acid)] as chromogen. Attempts were
made to measure secreted TGFβ using either a commercial ELISA kit
(Promega) or the plasminogen activator inhibitor 1 (PA1)-luciferase
assay described by Abe et al. (Abe et al., 1994). For the latter assay,
mink lung epithelial cells (MLEC, clone 32) stably transfected with
PA1-luciferase, were kindly provided by Dr D. Rifkin (New York,
NY). Neither assay proved to be sufficiently sensitive to measure
secreted TGFβ2.
Nuclear translocation of SMADs
To study nuclear translocation of SMAD, primary hippocampal
neurons (7 d.i.v.), were transfected with pEGFP-SMAD2 or pEGFP-
SMAD4 (kindly provided by Dr Kelly Mayo, Evanston, IL).
Transfection was carried out using 1 µg DNA/well and Lipofectamine
2000. Transfection efficiency, judged in control transfections with
pEGFP, was ~10%. Following transfection, cells were returned (3
hours) to standard growing medium or CMCerebellum or exposed to
TGFβ2 (1 ng/ml) or BDNF (100 ng/ml), stained with Hoechst 33342
and examined.
Receptor signaling
Analysis of BDNF (TRKB) and TGFβ receptor (TGFβ-RII) signaling
was studied in primary hippocampal cells after transfection (see
above) with 1 µg/well of the following plasmids: dominant-negative
TGFβRII (pRK5-TβRII-DN-F; generously provided by Dr R.
Derynck, San Francisco, CA, USA) and TRKB dominant-negative
(pEF/BOS-TRKB.T1-Flag; kind gift from Dr Eero Castren, Helsinki,
Finland); pEGFP was used as an internal control. Twenty-four hours
after transfection and exposure to either control or CMCerebellum, the
number of BrdU-positive or MAP2a/b-positive cells was counted as
a proportion of all cells (stained with Hoechst 33342). Transfection
efficiency was approximately 10%.
SMAD signaling
Analysis of SMAD signaling was studied in primary hippocampal
cells after transfection (see above) with 1 µg/well of either dominant-
negative SMAD3 [pCS2-FLAG-SMAD3(3S-A)] or dominant-
negative SMAD4 [pCMV5-FLAG-DPC4(1-514)] (provided by Dr
Joan Massague, New York, NY); pEGFP was used as an internal
control. Transfection efficiency was ~10%. Twenty-four hours after
transfection and exposure to either control or CMCerebellum, the number
of BrdU-positive or MAP2a/b-positive cells were assessed with
respect to the number of Hoechst 33342-stained cells.
3TP-Lux reporter assay
The p3TP-Lux reporter gene, containing a known TGFβ-inducible
plasminogen activator inhibitor promoter (Wrana et al., 1994)
(provided by Dr J. Massague), was transfected into HiB5 cells seeded
in 24-well plates (4104 cells per well), together with dominant-
negative SMADs, dominant-negative TRKB and TGFβRII, or wild-
type BDNF. Plasmid (625 ng of total DNA) was introduced using
Lipofectamine 2000 into cells maintained in Neurobasal A
medium/B27 supplement. Twenty-four hours after transfection
(efficiency ~10%), cells were treated with CMCerebellum (10 µl/ml).
Cells were lysed after 24 hours in 100 µl of 1 lysis buffer (Promega),
cleared by centrifugation and assayed for β-gal and luciferase activity.
For β-gal detection, 10 µl of cellular extract was mixed with 100 µl
of β-gal buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1
mM MgCl2, 2 mM β-mercaptoethanol) and 20 µl of O-nitrophenyl-
β-D-galactopyranoside (Sigma). The reaction was terminated with 50
µl of Na2CO3 (1 M) and luciferase activity was measured by mixing
30 µl of cellular extract with 50 µl of a buffer containing 75 mM Tris-
HCl and 1 mM MgCl2 (pH 8). Substrate D-(–) Luciferin (1 mM) was
automatically injected and light emission (410 nm) was measured over
20 seconds in a luminometer.
Statistical analysis
All data are depicted as mean±s.d. and represent the observations from
three to five independent experiments, with three or four replicates for
each data point. Data were analyzed for statistical significance using
ANOVA and appropriate post-hoc tests (Student-Newman-Keuls or
Kruskal-Wallis multiple comparison procedures) in which P<0.05
was set as the minimum level of significance.
Results
Spontaneous expression of markers of neuronal
proliferation, differentiation and apoptosis
Hippocampal and cerebellar cultures (8-19 d.i.v.) displayed a
dense network of neurites specifically labeled with TuJ1 (anti-
tubulin-βIII) (Fig. 1A). Postmitotic cerebellar cells were
evidenced by positive labeling with anti-MATH1, a basic helix-
loop-helix (bHLH) transcription factor known to be essential
for cerebellar granule cell development (Ben-Arie et al., 1997),
and with anti-MASH1, a neuronal commitment gene (Ross et
al., 2003). Hippocampal cultures were MATH1 negative and
MASH1 positive, indicating the presence of immature neurons
(Pleasure et al., 2000). Cerebellar and hippocampal cultures
displayed mitosis (BrdU incorporation; blue-black nuclei)
and apoptosis (brown, TUNEL-stained cells with nuclear
fragmentation) concomitantly.
Cerebellar ‘stop’ signals vs. hippocampal ‘go’
signals
BrdU incorporation by hippocampal cultures maintained in
conditioned medium derived from cerebellar cultures
(CMCerebellum) was used to test the hypothesis that cerebellar
cells secrete factors that can serve as an ‘instructive’ micro-
environment. As shown in Fig. 1B, exposure of hippocampal
cultures to CMCerebellum resulted in a significant reduction in
BrdU incorporation (P<0.001); the converse experiment
(cerebellar cultures treated with CMHippocampus) resulted in a
significant increase of BrdU-positive cerebellar cells (P<0.01)
(Fig. 1C). Similar results were obtained when hippocampal and
cerebellar slices (donor age: 7 days) were co-cultured for 7
days. Monitoring of BrdU retention (20 µM, final 24 hours;
Fig. 1D) showed that cell proliferation in hippocampal slices
was significantly reduced in the presence of cerebellar slices
when compared with when hippocampal slices were grown
alone (P<0.01); by contrast, cell proliferation in cerebellar
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slices was slightly, but not significantly, increased in the
presence of hippocampal tissue.
The above results indicate that soluble factors with mitotic
and anti-proliferative properties are secreted into CMHippocampus
and CMCerebellum, respectively; the remainder of our
investigations focused on the anti-proliferative activity of
CMCerebellum on hippocampal cells. Incubation of hippocampal
cell cultures with varying volumes of 100-fold concentrated
CMCerebellum established that its putative anti-proliferative
activity dose-dependently reduces BrdU incorporation in
primary hippocampal cells (Fig. 1E) and in a hippocampus-
derived cell line, HiB5 (Fig. 1F). An insight into the
physicochemical nature of the putative anti-proliferative
factor(s) was gained by assaying the effects of boiled 100-fold
concentrated CMCerebellum on BrdU incorporation by recipient
hippocampal cells. As Fig. 1E (last column) shows, the anti-
mitotic activity of CMCerebellum was abolished by boiling for 15
minutes, pointing to the peptidergic/proteinaceous nature of the
anti-proliferative moieties.
Expression of negative regulators of the cell cycle
and markers of neuronal differentiation
A series of experiments showed that factors present in
CMCerebellum can induce cell cycle arrest within that
subpopulation of cells destined to become neurons while
simultaneously accelerating neuronal maturation. CMCerebellum-
induced arrest of progression through the cell cycle was
demonstrated (western blot analysis) by increased expression
of the cyclin-dependent kinase (CDK) inhibitors, p21 and p27
(Fig. 2A). These changes were accompanied by enhanced
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Fig. 1. Cerebellar ‘stop’
versus hippocampal ‘go’
signals. (A) Characteristics
of hippocampal and
cerebellar neuronal cultures
under basal conditions,
showing expression of the
neuronal markers TuJ1,
MASH1 and MATH1, and
levels of apoptosis (TUNEL,
dark brown) and
proliferation (BrdU
incorporation, blue-black).
(B,C) Exposure of
hippocampal cells to
CMCerebellum reduces BrdU
incorporation (B); exposure
of cerebellar cultures to
CMHippocampus stimulates
BrdU uptake (C). (D) In
hippocampal-cerebellar slice
co-cultures, hippocampal
cell proliferation is reduced
in the presence of cerebellar
slices, whereas cerebellar
cell proliferation is slightly
increased in the presence of
hippocampal tissue. Dose
dependency of CMCerebellum
anti-mitotic effects in
hippocampal cultures are
shown in E; the peptidergic
nature of the anti-
proliferative activity present
in CMCerebellum is indicated
by the fact that anti-
proliferative activity is lost
after boiling CMCerebellum.
CMCerebellum also exerts anti-
proliferative effects on
hippocampus-derived HiB5
cells (F). Scale bar: 50 µm.
Numerical data refer to
mean±s.d. (n=4-6) *P<0.05,
**P<0.01, ***P<0.001
(versus appropriate
controls).
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numbers of cells displaying signs of
neuronal maturity (immunofluorescence
and/or western blot analysis); specifically,
exposure to CMCerebellum resulted in
increased synapsin (not shown) and
MAP2a/b (Fig. 2B,C) expression and,
concomitantly, in a small but significant
(P<0.05) decrease in the number of cells
immunoreactive for the marker of early
postmitotic neuroblasts, doublecortin (Fig.
2D). Interestingly, CMCerebellum had no
significant effect on the relative number of
glial (GFAP-immunopositive) cells in the
hippocampal cultures (data not shown); in
fact, the majority of BrdU-positive cells in
hippocampal cultures grown in CMCerebellum
had differentiated into neurons after 3 days,
as shown by double-labeling for BrdU and
MAP2a/b (Fig. 2E).
Presence of multiple factors with
differing anti-proliferative and pro-
differentiation or pro-apoptotic
properties in CMCerebellum
On the premise that more than one factor
may account for the anti-mitotic actions of
CMCerebellum, concentrated CMCerebellum was
fractionated according to ionic strength after
minimizing albumin interference using
Affigel Blue chromatography. The four
fractions that were eluted with NaCl (0.1-1.5
M) showed differing potencies on the
proliferative, differentiating and apoptotic
potential of hippocampal cells (Table 1).
Specifically, fractions eluting at 0.1 M NaCl
had significant anti-mitotic (P<0.001) and
anti-apoptotic (P<0.05) activities; fractions
eluting at 1 M NaCl proved effective at
promoting neuronal maturation (P<0.05)
and strong anti-apoptotic activity was
observed in eluates containing 1.5 M NaCl
(P<0.001). Thus, CMCerebellum contains a
cocktail of factors that differentially direct
hippocampal cell fate. Non-fractionated
CMCerebellum did not elicit any significant
change in the incidence of apoptosis
(F11,24=1.373, P=0.28; Table 1).
Identification of anti-proliferative and
differentiating factors
Data reported above indicated that the active factor(s) of
interest in CMCerebellum were heat unstable and had a Mr greater
than 6 kDa. Accordingly, we analyzed the effects of
immunoneutralization of three candidate trophic factors,
previously implicated in neuronal birth, differentiation and
death, namely, NGF, BDNF and TGFβ2 (Minichilo and Klein,
1996; Massague et al., 2000; Borghesani et al., 2002; Vaudry
et al., 2003), on BrdU incorporation and differentiation
(MAP2a/b expression). Immunocytochemistry showed the
presence of all these peptides in cerebellar and hippocampal
cultures (data not shown). BrdU incorporation by hippocampal
cells was not affected after incubation in anti-NGF-
preadsorbed CMCerebellum. Anti-BDNF (1:10) significantly
blocked the anti-proliferative effects of crude CMCerebellum
(P<0.05), as did anti-TGFβ2 (1:1000 and 1:100; P<0.01) (Fig.
3A). Control cultures (treated with species-appropriate purified
IgG preparations) did not differ from naive controls (data not
shown).
In accordance with our earlier results that showed
that CMCerebellum concomitantly blocks proliferation of
hippocampal cells while promoting their maturation
(Fig. 2), immunoneutralization against TGFβ2 (antibody
Fig. 2. Hippocampal cultures express markers of cell
cycle inhibition and neuronal differentiation after
incubation in CMCerebellum. (A-D) Western blots and/or
immunofluorescence staining show that addition of
CMCerebellum (10 µl/ml) to hippocampal cultures induces
expression of the cyclin-dependent kinase inhibitors p21
and p27 (A) and of the mature neuron marker
MAP2A/MAP2B (B,C) with concomitant decreases in
the expression of the neuroblast marker, doublecortin
(D). Insets show examples of immunoblots for p21 (A)
and p27 (A) and MAP2A/MAP2B (B), as well as for
actin (which served as an internal reference). Results
shown in A-D were obtained after 24 hours treatment
with CMCerebellum. (E) CMCerebellum treatment influences
proliferation and differentiation of neurons as shown by
the significantly increased number of MAP2A/MAP2B-
positive/BrdU-positive double-stained cells relative to the total number of BrdU-positive
cell population. For this analysis, cells growing in CMCerebellum were exposed to BrdU for
8 hours, and washed and maintained in CMCerebellum for 72 hours before fixing and
processing for MAP2A/MAP2B and BrdU double immunocytochemistry. There was no
statistical difference on the incidence of apoptosis in cultures grown in either control
medium or CMCerebellum. Numerical data refer to mean±s.d. (n=4-6) *P<0.05, **P<0.01,
***P<0.001 (versus appropriate controls).
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concentrations that proved efficient at reversing the anti-
mitotic effects) significantly reduced MAP2a/b expression
(P<0.01; Fig. 3B). By contrast, anti-NGF (which did not
influence proliferation) and anti-BDNF did not alter the
relative number of MAP2a/b-immunoreactive cells, when
compared with CMCerebellum that had not been pre-adsorbed
with these antisera (Fig. 3B).
As immunoneutralization experiments provide only
qualitative information and may be compromised by factors
such as antibody affinity and purity, we next examined
hippocampal cell proliferation and maturation after addition
of either BDNF or TGFβ2 to normal medium; for
comparison, hippocampal cultures were grown in
CMCerebellum. Significant reductions in BrdU incorporation
were observed after treatment with either BDNF at 50 ng/ml
(P<0.05) and 100 ng/ml (P<0.001) (Fig. 3C) or TGFβ2 at 1
ng/ml (P<0.01) and 10 ng/ml (P<0.01) (Fig. 3D). The results
obtained with exogenous BDNF peptide were confirmed
when hippocampal cells were transfected with a BDNF
expression plasmid (P<0.001, compared with cells
transfected with pEGFP; inset, Fig. 3C) and when medium
from pBDNF-transfected cells (24 hours) was added to
pEGFP-transfected cells (third bar in inset, Fig. 3C; P<0.01).
In addition to inhibiting cell proliferation, both exogenous
BDNF and TGFβ2 were found to promote neuronal
maturation, evidenced by significant increases (P<0.01 and
0.05, respectively) in the number of MAP2a/b-
immunopositive cells after addition of purified forms of each
peptide (Fig. 3E). These findings indicate that BDNF
and TGFβ2 account for a large part of the pro-neuronal
properties of CMCerebellum. Using another indicator of pro-
neuronal activity, namely neurite extension (‘long neurites’
defined as neurites with lengths that were more than twice the
diameter of the cell body), we observed that both BDNF (at
10-100 ng/ml; P<0.05) and TGFβ2 (at 1-10 ng/ml; P<0.05)
stimulated neurite growth in a manner comparable with that
observed with CMCerebellum (Fig. 3E).
The temporal patterns of BDNF and TGFβ2 expression in
hippocampal and cerebellar cultures were examined using
immunocytochemistry after varying numbers of days in vitro.
Generally, the intensity of BDNF and TGFβ2 staining was
stronger in cerebellar versus hippocampal cultures (data not
shown). When compared with hippocampal cells, a
significantly larger number of cerebellar cells expressed
BDNF on 3 and 6 d.i.v. (P<0.001 and P<0.05; data not
shown). At 9 d.i.v. (peak), more cerebellar cells than
hippocampal cells were immunoreactive for TGFβ2 (P<0.05;
data not shown).
Anti-proliferative and differentiating effects of
CMCerebellum are mediated by TRKB and TGFβ-RII
receptors
CMCerebellum failed to inhibit proliferation in primary
hippocampal cells expressing dominant-negative forms of the
BDNF receptor TRKB (pEF/BOS-TRKB.T1-flag) or the
TGFβ receptor, TGFβ-RII (pRK5-TβRII-DN-F) (Fig. 4A). In
addition, hippocampal neuronal maturation induced by
CMCerebellum, as measured by the number of MAP2a/b-
immunoreactive cells, was significantly reduced in cells
expressing dominant-negative forms of TRKB and TGFβ-RII
(Fig. 4B). These results add further support for the roles
of BDNF and TGFβ-2 as the anti-proliferative and pro-
differentiation moieties in CMCerebellum.
Mediation of CMCerebellum, BDNF and TGFβ2 actions
by SMAD pathways
TGFβ2 exerts its biological actions through the mediation of
SMAD proteins. SMAD2 and SMAD3 specifically transduce
TGFβ signals after dimerizing with co-SMAD4, translocating
the resulting complex to the nucleus and modulating the
transcriptional machinery (Attisano and Wrana, 2002). The
data depicted in Fig. 4C show that pEGFP-SMAD2 and
pEGFP-SMAD4 are translocated to the nucleus after exposure
of primary hippocampal neurons to CMCerebellum, as well as to
purified TGFβ2 and BDNF.
We showed in Fig. 1F that, as in primary hippocampal cells,
CMCerebellum exerts anti-mitotic actions in the hippocampus-
derived HiB5 cell line. CMCerebellum failed to inhibit
proliferation or to stimulate differentiation in hippocampal
cells expressing dominant-negative forms of SMAD3 (pCS2-
FLAG-SMAD3-3SA) or co-SMAD4 (pCMV-FLAG-DPC4(1-
514)) (Fig. 4D,E).
Another set of experiments in HiB5 cells showed that
CMCerebellum dose-dependently transactivates the specific
SMAD reporter gene 3TP-Lux (Fig. 4F). Stimulation of
reporter gene activity was abolished in the presence of
dominant-negative forms of SMAD3 (pCS2-FLAG-SMAD3-
3SA) or co-SMAD4 (pCMV-FLAG-DPC4(1-514) (Fig. 4G),
again pointing to the involvement of SMAD signaling in the
mediation of CMCerebellum actions. These and the other above-
reported data do not, however, completely rule out the
participation of other SMAD-linked factors, as co-SMAD4
complexes with other members of the SMAD family,
independently of TGFβ; indeed, as functional inhibition
of SMAD4 resulted in stronger (P<0.01) inhibition of the
anti-proliferative and differentiating effects of CMCerebellum
(Fig. 4D,E), when compared with those observed after
SMAD3 inhibition, activation of other SMAD pathways by
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Table 1. Proliferative, differentiating and apoptotic
activities in different fractions of CMCerebellar purified by
ion-exchange chromatography
Biological activity
Proliferative Differentiating Apoptotic
Medium (% BrdU+ cells) (% MAP2+ cells) (% TUNEL+ cells)
Control 45.1±3.9 15.2±1.6 22.7±1.3
CMCerebellarCrude 13.5±1.2 26.4±0.5 27.1±1.5
Q-ion exchange chromatography CMCerebellum
Eluate, 0.1 M NaCl 18.5±1.4 16.5±0.8 16.3±1.2
Eluate, 0.5 M NaCl 38.1±3.5 13.4±0.5 21.8±2.2
Eluate, 1 M NaCl 46.9±0.8 22.2±1.2 22.6±4.1
Eluate, 1.5 M NaCl 46.5±1.9 19.2±2.8 8.7±1.3
Multiple factors in CMCerebellum contribute to its anti-proliferative, anti-
apoptotic and differentiation-inducing properties. Concentrated CMCerebellum
was fractionated according to ionic strength and dye affinity (Q and Affigel
Blue chromatography). The four fractions that eluted with NaCl (0.1-1.5 M)
differentially influenced proliferation, apoptosis and differentiation in primary
hippocampal cells. Specifically, fractions with 0.1 M NaCl displayed
significant anti-mitotic (P<0.001) and anti-apoptotic (P<0.05) effects; strong
anti-apoptotic activity was observed in fractions eluting with 1.5 M NaCl
(P<0.001), whereas those eluting with 1 M NaCl promoted neuronal
maturation (P<0.05). 
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non-TGFβ ligands is highly plausible (see Attisano and
Wrana, 2002).
Last, as shown in Fig. 4H, CMCerebellum transactivation of the
3TP-Lux SMAD reporter gene was significantly attenuated
(P<0.01) when HiB5 cells were transfected with plasmids
expressing the dominant-negative forms of TGFβRII or TRKB.
These data demonstrate the essential role of TGFβRII or
TRKB receptors in coupling CMCerebellum-initiated signals
(putatively, through TGFβ2 and BDNF, respectively) with the
SMAD signaling cascade.
BDNF actions involve convergence of MAPK and
SMAD signaling pathways
Adding to the evidence that TGFβRII are involved in mediating
the biological actions of BDNF, we observed that BDNF failed
to exert anti-proliferative effects when it was applied to
primary hippocampal cells that were transiently transfected
with a dominant-negative form of TGFβRII (Fig. 5A).
As BDNF signaling pathways reportedly converge on those
triggered by TGFβ2 following the activation of ERK1/2 by the
neurotrophin (Segal and Greenberg, 1996; Pera et al., 2003),
we pharmacologically tested the involvement of these kinases
using the MEK inhibitor PD98059. This drug significantly
abrogated the inhibitory effects of CMCerebellum on BrdU
incorporation (P<0.001; Fig. 5B). PD98059 also abolished the
pro-differentiating potential of CMCerebellum (P<0.001; Fig.
5C). Together, these observations indicate that CMCerebellum-
induced effects on proliferation and differentiation are
mediated through MAP kinases and, in accordance with earlier
reports (Marshall, 1995; Du et al., 2003), they hint at the
involvement of BDNF in these
processes.
We showed earlier that CMCerebellum-
stimulated 3TP-Lux reporter activity
was attenuated when HiB cells were
transiently transfected with a dominant-
negative form of the BDNF receptor
TRKB. In another set of experiments,
we showed that expression of pBDNF
also significantly increased 3TP-Lux
reporter activity (Fig. 5D). However,
transactivation of the reporter was not
seen after co-transfection of cells with
pBDNF and (1) dominant-negative
TRKB, (2) dominant-negative SMAD4
or (3) PD98059 (Fig. 5D). These results
Fig. 3. Immunoneutralization of candidate
anti-proliferative and differentiating factors
in CMCerebellum and replication of effects by
exogenous BDNF and TGFβ2.
(A) CMCerebellum was preadsorbed with the
indicated dilutions of anti-NGF, BDNF or
TGFβ2. (B) Immunoneutralization of
BDNF and TGFβ2 significantly attenuates
the anti-proliferative actions of
CMCerebellum; anti-TGFβ2 significantly
attenuates the pro-differentiating effects of
CMCerebellum, assessed by MAP2A/MAP2B
expression. (C,D) Exogenous BDNF (C)
and TGFβ2 (D) dose-dependently inhibit
BrdU retention in hippocampal cells; the
inset (C), shows that transient expression of
pBDNF also reduces BrdU incorporation
(pEGFP used as transfection control).
(E) Exogenous BDNF and TGFβ2 promote
neuronal maturation in hippocampal
cultures (increased expression of
MAP2A/MAP2B and neurons with neurite
lengths more than twice the diameter of the
soma). The control data in E, shown as
100%, represent 126/865 MAP2-positive
cells (14.5%) with ‘long neurites’ in the
BDNF studies, and 94/518 MAP2-positive
cells (18.2%) with ‘long neurites’ in the
TGFβ2 experiments. Numerical data refer
to mean±s.d. (n=4-6) *P<0.05, **P<0.01,
***P<0.001 (versus appropriate controls).
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demonstrate that MAP kinases mediate the actions of BDNF
on SMAD signaling. Interestingly, co-transfection of pBDNF
with a dominant-negative form of the TGFβRII also abrogated
BDNF-stimulated activity of the 3TP-Lux reporter (Fig. 5D),
indicating that the TGFβRII is involved in the mediation of
BDNF actions. This finding led us to examine the possibility
that BDNF can stimulate TGFβ2 synthesis/secretion. Using a
semi-quantitative immunocytochemical assay, we observed
that exposure of primary hippocampal cells to BDNF (10-100
ng/ml) can dose-dependently increase the cellular content of
TGFβ2 (Fig. 5E). Two different assay systems used to detect
secreted TGFβ2 proved to be insufficiently sensitive (cf. Lutz
et al., 2004).
Discussion
The pluripotency of neural cell progenitors (McConnell and
Kaznowski, 1991; Coskun and Luskin, 2002) implies that
their ultimate phenotype can be influenced by environmental
factors. Phenotypic re-specification has been demonstrated, for
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Fig. 4. Involvement of
TRKB/TGFβ-RII and TGFβ2
signaling pathways in the anti-
mitotic and differentiating effects of
CMCerebellum. (A) Transfection of
cells with a dominant-negative form
(∆) of TRKB (∆TRKB) or TGFβ
receptor II (∆TGFβ-RII) before
treatment with CMCerebellum resulted
in a significant increase in
proliferation (versus controls
transfected with GFP) (100% refers
to BrdU incorporation in absence of
CMCerebellum). (B) Results from cells
treated as described above show that
inhibition of expression of TGFβ-
RII or TRKB prevents CMCerebellum-
induced neuronal differentiation, as
measured by number of
MAP2A/MAP2B-positive cells
(cells not exposed to CMCerebellum
provide the reference value of
100%). (C) Exposure of
hippocampal cells to CMCerebellum,
as well as to either TGFβ2 (1
ng/ml) or BDNF (100 ng/ml)
induces nuclear translocation of the
TGFβ2-specific partner SMAD2
and of co-SMAD4 within 3 hours,
as shown by transient transfection
experiments. (D,E) Introduction of
dominant-negative forms of either
SMAD3 (which specifically couples
with TGFβ2) or of Co-SMAD4
abrogates the anti-mitotic (D) and
differentiating (E) effects of
CMCerebellum on primary
hippocampal cells; these changes do
not reflect apoptosis as the number
of TUNEL-stained and activated
caspase 3 cells were not altered by
the treatment (data not shown). (F-
H) CMCerebellum stimulates
generation of luciferase from the
TGFβ reporter gene 3TP-Lux in
HiB5 cells (F), an effect abrogated
when expression of either SMAD3
or Co-SMAD4 is blocked by
transfection with their respective dominant-negative (∆) forms (G); similarly, transactivation of 3TP-Lux is blocked in the presence of
∆TGFβ-RII and ∆TRKB (H). Each half set of data in A,B,D,E were obtained in independent experiments in which GFP was used to control
for between-culture variability in transfection efficiency. Data in G,H represent ratios of luciferase expression (fold change in treatments
versus non-treated cells). In all cases, transfections were performed 24 hours before addition of CMCerebellum, TGFβ2 or BDNF for 24 hours,
after which the analysis was performed. Numerical data refer to mean±s.d. (n=4-6) *P<0.05, **P<0.01, ***P<0.001 (versus appropriate
controls).
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example, in studies involving hippocampal granule cell
transplants into the cerebellum (Renfranz et al., 1991) and vice
versa (Vicario-Abejón et al., 1995). This adaptive capacity,
resulting from the interplay between lineage-specific and
extrinsic factors, is gradually lost over time as the host
environment becomes increasingly differentiated (Suhonen et
al., 1996; Alder et al., 1999); thus, these processes appear to
be spatiotemporally organized. Another intriguing aspect of
neuronal development concerns the determination of optimal
neuronal population sizes. It is recognized that rates of
apoptosis and neurogenesis from embryonic development
through to adulthood occur in a balanced manner. Earlier
studies have suggested that autocrine or paracrine secretions
may play a role in the proliferation, survival and differentiation
of developing granule neurons (Gao et al., 1991; Mumm et al.,
1996; Ueki et al., 2003; Wu et al., 2003). Although various
experimental paradigms have indicated regulatory roles for the
neurotrophin BDNF in these events (Lin et al., 1998;
Borghesani et al., 2002) and other cytokines (Tao et al., 1997;
Unsicker and Strelau, 2000; Pratt and McPherson, 1997; Alder
et al., 1999; Angley et al., 2003), little is known about the
identity of the intrinsic and environmental signals that maintain
the equilibrium between neuronal birth, maturation and death.
The appearance and differentiation of cerebellar and
hippocampal granule neurons overlap only transiently:
cerebellar granule cells enter a post-mitotic state at P7-14, i.e.
when hippocampal granule cell neurogenesis peaks before
gradually declining with increasing age (Schlessinger et al.,
1975; Altman and Bayer, 1990; Cameron and McKay, 2001).
A recent DNA microarray analysis revealed that cerebellar and
hippocampal granule cells display distinct gene expression
profiles, even at times when both cell types are undergoing
rapid mitosis (Saito et al., 2002).
In an analogous approach to those used previously in
animals (Renfranz et al., 1991; Vicario-Abejón et al., 1995),
the different developmental profiles in the hippocampus and
cerebellum were exploited in the present study to identify
factors contributing to the regulation of hippocampal granule
cell proliferation and differentiation. By
immunocytochemical monitoring of
markers of neuronal maturity and
proliferative potential (BrdU
incorporation) in hippocampal and
cerebellar cultures from animals of a given
developmental age, we confirmed that,
when compared with hippocampal
cultures, cerebellar cultures were more
mature and mainly postmitotic after 14
d.i.v. Next, cultures of one type were
treated with conditioned medium from the
other (CMCerebellum and CMHippocampus).
Analysis of BrdU uptake revealed that
whereas CMHippocampus stimulated
proliferation in cerebellar cultures,
CMCerebellum treatment inhibited cell
proliferation and accelerated neuronal
maturation in hippocampal cultures
in a dose-dependent manner. The anti-
Fig. 5. Mechanisms underlying the anti-mitotic
and differentiating effects of CMCerebellum and
BDNF – possible opportunities for crosstalk
with TGFβ signaling pathways. The anti-
proliferative effects of BDNF (measured by
BrdU incorporation) are significantly
attenuated in primary hippocampal cells
expressing a dominant-negative form of TGFβ-
RII. (B,C) The MEK inhibitor PD98059 (0.1
µM) counteracts the anti-proliferative (B) and
pro-differentiating (C) effects of BDNF.
(D) Transient transfection of HiB5 cells with
pBDNF results in increased TGFβ2 reporter
gene (3TP-Lux) expression, an effect that is
significantly attenuated by co-transfecting
dominant-negative forms (∆) of either TRKB,
TGFβ-RII or SMAD4, or by pretreatment with
PD98059. (E) BDNF dose-dependently
increases TGFβ2 protein content in primary
hippocampal cells; numerical data refer to
mean±s.d. (n=4-6) *P<0.05, **P<0.01,
***P<0.001 (versus appropriate controls).
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proliferative/pro-differentiating effects of CMCerebellum
coincided with increased expression of p21 and p27, two cell
cycle arrest-related molecules. Similar results were obtained
after treating hippocampus-cerebellum slice co-cultures or a
hippocampus-derived cell line (HiB5) with CMCerebellum.
Together, these results indicate that cerebellar and hippocampal
cells secrete cell type-specific factors in a temporally
coordinated manner, and that these factors exert distinct
influences on neurogenesis and differentiation.
The loss of biological activity after boiling CMCerebellum
hinted at the polypeptide nature of its anti-proliferative/pro-
differentiating activities. Importantly, biological potency was
retained in CMCerebellum that was subjected to ion exchange
chromatography, but the anti-mitotic, apoptotic and
differentiating activities eluted at different ionic strengths.
Immunoneutralization was used as an approach to identify the
active moieties in CMCerebellum; the selection of candidates
was based on reports that TGFβ2, NGF and BDNF are
differentially expressed in hippocampal and cerebellar tissues
during development (Unsicker et al., 1991; Sakamoto et
al., 1998; Dieni and Rees, 2002). We found that
immunoneutralization of BDNF and TGFβ2, but not NGF,
abrogated the proliferative actions of CMCerebellum. At the same
time, pre-adsorption of CMCerebellum with anti-TGFβ2 (but not
anti-BDNF or anti-NGF) inhibited the pro-differentiating
actions of CMCerebellum.
Further studies focused on verifying the roles of TGFβ2
and BDNF in the observed CMCerebellum-induced effects on
hippocampal cell development. Both TGFβ2 and BDNF were
found to be more strongly expressed in age-matched cerebellar
versus hippocampal cultures (data not shown), and treatment
of hippocampal cultures with either cytokine resulted in
reduced BrdU incorporation and increased signs of neuronal
differentiation.
Three separate genes encode three isoforms of TGFβ:
TGFβ1 (normally restricted to the choroid plexus); and the
neuron- and glia-expressed isoforms TGFβ2 and TGFβ3
(Unsicker et al., 1991; Pratt and McPherson, 1997). TGFβ1
and TGFβ3 have been implicated in neuroprotection, while
neurotrophic functions have been ascribed to TGFβ2 and
TGFβ3 (Finch et al., 1993; Böttner et al., 2000; Pratt
and McPherson, 1997). The latter include stimulation
(Mahanthappa and Schwarting, 1993) or inhibition (Constam
et al., 1994) of neurogenesis, or both (Kane et al., 1996), as
well as the regulation of neuronal differentiation (Ishihara et
al., 1994; Abe et al., 1996; Cameron et al., 1998). TGFβ2, the
isoform focused on in this work, is expressed in the external
granular (neurogenic) layer and in Purkinje and radial glia of
the cerebellum according to a strict temporal pattern and,
interestingly, appreciable levels of TGFβ2 are not seen in other
brain sites of neuronal proliferation (Flanders et al., 1991;
Constam et al., 1994; Unsicker and Strelau, 2000).
Members of the TGFβ superfamily signal by sequentially
binding to two TGFβ receptors (TGFβ-R) that are
transmembrane protein serine/threonine kinases; binding of
TGFβ ligand to TGFβ-RII activates TGFβ-RI (expressed in the
developing and adult rat hippocampus) (Böttner et al., 1996)
and its substrates, the receptor-regulated SMAD proteins (R-
SMADs). Upon phosphorylation, the latter bind co-SMAD4
and translocate to the nucleus where they form a
transcriptionally active complex after association with DNA-
binding partner(s). This complex binds to promoter elements
of target genes whose functions include regulation of the cell
cycle and differentiation (Moustakas et al., 2001; Chang et al.,
2002; Shi and Massagué, 2003). For example, cell cycle arrest
by TGFβ involves suppression of the oncogene Myc, a
repressor of the CDK inhibitors p21 and p27 (Seoane et al.,
2002; Gartel and Shchors, 2003). Supporting the view that
TGFβ2 may be responsible for at least some of the anti-
mitogenic activity of CMCerebellum we here observed an
upregulation of p21 and p27 after CMCerebellum treatment of
proliferating hippocampal neurons.
Additional evidence for a key role of TGFβ2 in the
hippocampal cell fate-determining actions of CMCerebellum
was obtained by studying TGFβ signal-propagating SMAD
proteins. Of the various members of the SMAD system,
SMAD2 and SMAD3 mediate TGFβ signals. SMAD4 is a
requisite partner for transcriptional activity of all SMADs,
including SMAD2 and SMAD3; the generation of specific
downstream responses is presumed to depend on the formation
of specific R-SMAD-SMAD4 complexes that then recruit
different sequence-specific DNA-binding factors (Massagué
and Wotton, 2000). We demonstrated that CMCerebellum
treatment can induce nuclear translocation of EGFP-SMAD2
and EGFP-SMAD4. Essential roles for SMAD3 and SMAD4
were demonstrated insofar that transient expression of the
dominant-negative forms of either of these molecules
in hippocampal cells prevented CMCerebellum-induced
transactivation of the TGFβ reporter gene (3TP-Lux) and
abrogated the anti-proliferative and pro-differentiating effects
of CMCerebellum. Further support for the view that TGFβ2, at
least partially, accounts for the anti-proliferative activity
present in CMCerebellum is provided by the observation that
expression of a vector containing a dominant-negative form
of TGFβRII in either primary hippocampal cells or a
hippocampus-derived cell line (Hib5) abolishes CMCerebellum-
induced effects on BrdU incorporation and 3TP-Lux reporter
activity.
As already mentioned, hippocampal cells responded to
exogenous BDNF (or a BDNF-expressing plasmid) with an
inhibition of BrdU uptake, and an increase in the number of
MAP2a/b neurons and neuritic lengths; the effects of this
neurotrophin therefore closely resembled those of TGFβ2.
BDNF effects on neuronal differentiation are mediated
through TRKB receptors (Klein et al., 1991) and BDNF can
either promote or inhibit neuronal proliferation by activating
the TRK-MAPK-ERK pathway (Marshall, 1995; Du et al.,
2003), thus raising the issue of whether ERK signaling is
involved in the biological actions of CMCerebellum. We found
that upstream (MEK) inhibition of this pathway using
PD98059 negates the proliferative and differentiating actions
of CMCerebellum. Furthermore, we observed that transient
expression of a dominant-negative form of TRKB in
hippocampal cells abolishes CMCerebellum-induced effects on
proliferation and differentiation, while, at the same time,
abolishing the ability of CMCerebellum to induce nuclear
translocation of SMAD2 and SMAD4, and TGFβ 3TP-Lux
transactivation. These findings are consistent with previous
reports that suggested crosstalk (Lutz et al., 2004) or
interdependence/synergism (Unsicker and Strelau, 2000)
between these trophic factors and their signal transduction
pathways. Additional support for this interpretation is
Development 132 (14) Research article
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provided by our observation that BDNF cannot stimulate 3TP-
Lux reporter activity after functional blockade of SMAD4 and
TGFβ–RII expression, and that expression of a dominant-
negative form of TGFβRII attenuates the anti-proliferative
activity of BDNF. In an initial analysis of the upstream
mechanisms that might be responsible for crosstalk between
the BDNF and TGFβ pathways, we found that BDNF can
stimulate the cellular content of TGFβ2 in hippocampal cells;
unfortunately, limited assay sensitivity precluded information
on whether BDNF can also stimulate TGFβ2 secretion.
Seoane et al. (Seoane et al., 2002) showed that TGFβ can
induce cell cycle arrest by activating cdk inhibitors such as
p21 and p27. The present study shows that both these latter
proteins are upregulated in hippocampal cells after exposure
to CMCerebellum, raising the following questions for future
research. Do BDNF-activated TRKB receptors induce cell
cycle arrest? If so, is the TGFβ/SMAD pathway involved?
In summary, we have demonstrated that BDNF and TGFβ2
and their respective signaling machineries, by acting in a
dynamic, but strictly coordinated, spatiotemporal fashion, play
a decisive role in determining hippocampal cell fate by
inhibiting cell proliferation and promoting neuronal
differentiation. We have also shown that BDNF, better known
for TRK receptor-mediated promotion of neurogenesis and
differentiation (Klein et al., 1991; Gao et al., 1995; Pencea et
al., 2001), can exert anti-proliferative and pro-differentiating
effects on hippocampal granule cells by activating MAPK and,
subsequently, TGFβ signaling pathways; the latter is a novel
observation and provides a mechanism through which diverse
cytokine signals can converge on a common signaling ‘hub’ to
direct neuronal development.
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